Edition:
United States

Heska Corp (HSKA.OQ)

HSKA.OQ on NASDAQ Stock Exchange Capital Market

68.24USD
9 Dec 2016
Change (% chg)

$-0.33 (-0.48%)
Prev Close
$68.57
Open
$68.86
Day's High
$69.57
Day's Low
$67.86
Volume
19,623
Avg. Vol
27,597
52-wk High
$69.80
52-wk Low
$26.27

HSKA.OQ

Chart for HSKA.OQ

About

Heska Corporation develops, manufactures, markets, sells and supports veterinary products. The Company focuses on the canine and feline companion animal health markets. Its segments include Core Companion Animal Health segment, which includes, primarily for canine and feline use, blood testing instruments and supplies, digital... (more)

Overall

Beta: 0.81
Market Cap(Mil.): $473.00
Shares Outstanding(Mil.): 6.90
Dividend: --
Yield (%): --

Financials

  HSKA.OQ Industry Sector
P/E (TTM): 55.19 30.43 30.35
EPS (TTM): 1.24 -- --
ROI: 12.22 13.26 15.27
ROE: 13.08 17.03 16.60

BRIEF-Heska reports Q3 earnings per share $0.45

* Q3 earnings per share view $0.25 -- Thomson Reuters I/B/E/S Source text for Eikon: Further company coverage:

Nov 01 2016

BRIEF- John Mcmahon is promoted to chief financial officer of Heska

* John Mcmahon is promoted to chief financial officer Source text for Eikon: Further company coverage:

Sep 29 2016

BRIEF-Heska Q2 earnings per share $0.35

* Q2 earnings per share view $0.18, revenue view $28.5 million -- Thomson Reuters I/B/E/S Source text for Eikon: Further company coverage:

Aug 03 2016

Competitors

  Price Chg
Pfizer Inc. (PFE.N) $31.70 +0.76
Novartis AG (NOVN.S) CHF70.75 +2.25
Merck & Co., Inc. (MRK.N) $61.23 +1.11
Bayer AG (BAYGn.DE) €94.54 +1.37
Bayer AG (BAYE.F) -- --
Sanofi SA (SASY.PA) €76.33 +1.25
Eli Lilly and Co (LLY.N) $67.85 +0.66
IDEXX Laboratories, Inc. (IDXX.OQ) $118.24 -0.55
Virbac SA (VIRB.PA) €133.65 +0.80
Vetoquinol SA (VETO.PA) €48.10 +0.10

Earnings vs. Estimates